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Abstract
Background: National and international efforts like the 1000 Genomes Project are leading to increasing insights
in the genetic structure of populations worldwide. Variation between different populations necessitates access
to population-based genetic reference datasets. These data, which are important not only in clinical settings
but also to potentiate future transitions towards a more personalized public health approach, are currently not
available for the Belgian population.
Results: To obtain a representative genetic dataset of the Belgian population, participants in the 2013 National
Health Interview Survey (NHIS) were invited to donate saliva samples for DNA analysis. DNA was isolated and single
nucleotide polymorphisms (SNPs) were determined using a genome-wide SNP array of around 300,000 sites, resulting in
a high-quality dataset of 189 samples that was used for further analysis. A principal component analysis demonstrated
the typical European genetic constitution of the Belgian population, as compared to other continents. Within Europe,
the Belgian population could be clearly distinguished from other European populations. Furthermore, obvious signs from
recent migration were found, mainly from Southern Europe and Africa, corresponding with migration trends from the
past decades. Within Belgium, a small north-west to south-east gradient in genetic variability was noted, with differences
between Flanders and Wallonia.
Conclusions: This is the first study on the genetic structure of the Belgian population and its regional variation.
The Belgian genetic structure mirrors its geographic location in Europe with regional differences and clear signs
of recent migration.
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Background
After the completion of the Human Genome Project in
2003, international efforts were initiated to map human
genetic variation between populations. This variation has
been described for 26 populations worldwide via the 1000
Genomes Project [1, 2]. While this is a valuable resource
for studying global genetic variation, both the number of
samples per population and the total number of popula-
tions studied are relatively low. To gain sufficient statistical
power and avoid false positives/negatives due to unmatched
control populations in genotype-phenotype association
studies, population-based genetic reference data are re-
quired from more specific and extended populations [3].
To address this, population-based whole genome sequen-
cing initiatives have been performed at the national level
throughout Europe [4–7]. From these genetic population
studies, it has become clear that there is a strong correl-
ation between the geographical location and the genetic
structure of different populations [8, 9], also at the more re-
gional level (e.g., along a north-south axis in the
Netherlands) [6, 7, 9, 10]. Currently, this genetic informa-
tion is not available for the Belgian population.
Therefore, a population-based cross-sectional study,
called BelPHG-21 (Belgian Public Health Genomics in the
twenty-first century), was organized that aims at describing
the genetic variability in the Belgian population and relating
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this variability to several indicators of health and disease to
anticipate a future transition towards precision public
health. To accomplish this, the BelPHG-21 study was orga-
nized in the context of the 2013 Belgian National Health
Interview Survey (NHIS). The NHIS is a population-based
survey that has been periodically organized since 1997. It
has the purpose to assess the health status and its distribu-
tion in the population and to describe the association of
this health status with its main determinants [11].
Here, we report on the BelPHG-21 results related to
the genetic structure of the Belgian population. By in-
corporating NHIS information about the study subject’s
residence and parental country of birth, we demonstrate
small but clear genetic differences between different re-
gions and illustrate how the population’s genetic struc-
ture is shaped by recent migration waves.
Results
Factors determining consent for former NHIS participants
to participate in the BelPHG-21 population genetic study
To study the genetic structure and variability in the
Belgian population, a subset of participants from the
most recent NHIS, conducted on 10,829 inhabitants in
2013 [12], was invited to donate saliva samples for DNA
analysis (Fig. 1). From the invited subsample of 1468
individuals, 210 (14%) consented and submitted saliva
samples for DNA analysis. Using the NHIS information
related to demographics, education, employment,
income, health behavior, lifestyle characteristics, physical
and social environment, and wellbeing characteristics,
we applied a predictive weighted binomial regression
analysis to identify the factors that determined consent
to participate in this study. This resulted in a model con-
taining four variables (smoking behavior, education, age,
and region of residence) (Table 1). The odds for consent
were higher in non-smokers (and higher in former
smokers than never smokers), higher age, and higher
educational attainment. Furthermore, the likelihood for
consent was also higher in the Flemish Region compared
to the other regions.
DNA sampling from the Belgian population
DNA was extracted from saliva samples obtained from
210 consenting participants. Three of these samples
contained insufficient saliva, while the DNA concentra-
tion of eight other samples was considered too low for
downstream analysis (Fig. 1). From the remaining 199
samples, single nucleotide polymorphisms (SNPs) at ±
300,000 sites were measured using the whole genome
scanning Illumina HumanCytoSNP-12 microarray.
Microarray results from 10 samples were excluded due
to insufficient call rates (i.e., lower than 0.6), resulting
in 189 samples that were used for further analysis.
These samples were genotyped using the hg19 human
genome build as a reference and variant allele frequen-
cies were calculated for a total number of 261,079 SNPs
for which genotyping information was available
(Additional file 1: Table S1).
Belgium is composed of three different geographical
regions: Flanders, Brussels, and Wallonia. The 189 sam-
ples that were used for analysis in this study were
donated by volunteers in all three regions: 98 from
Flanders, 62 from Wallonia, and 29 from Brussels
Fig. 1 BelPHG-21 study flow chart, Belgium 2016
Table 1 Variables predicting consent, BelPHG-21 study, Belgium
2016
Variable Parameter OR 95% CI OR
Smoking habits (ref “Smoker”) Former smoker 2.21 [1.38, 3.62]
Never smoker 1.38 [0.92, 2.15]
Age Age (years) 1.02 [1.01, 1.02]
Residence (ref “Flanders”) Brussels’ region 0.45 [0.24, 0.77]
Walloon region 0.58 [0.41, 0.80]
Education (ref “No diploma”) Lower secondary 2.29 [1.38, 7.02]
Higher secondary 4.13 [2.12, 9.50]
Higher 6.66 [3.40, 15.44]
Not applicable 5.31 [2.25, 14.06]
A weighted binomial regression analysis to predict consent contained four
variables (smoking habits, age, residence, and education). For each parameter,
the odds ratio (OR) and 95% CI interval are given
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(Fig. 2). These numbers are proportional to the popu-
lation size of the respective regions with an overrep-
resentation from the Brussels region (15.3, 17.3, and
24.7 samples per million inhabitants for Flanders,
Wallonia, and Brussels respectively) (Additional file 2:
Table S2). This oversampling of the Brussels region is
related to the way the NHIS was constructed [11].
Similarly, the distribution of these samples was rela-
tively proportional to the population size from each
of 10 provinces in Belgium with a variation from 11.3
to 26.7 samples per million inhabitants (Fig. 2 and
Additional file 2: Table S2).
From the samples used for analysis, 35 (18.5%) were
donated by an individual with non-Belgian roots (here
defined as an individual whose mother and/or father
was born outside Belgium, as registered in NHIS).
These individuals mainly originated from neighboring
countries (16), Southern Europe (7), and Africa (6).
Proportionally, the highest numbers of non-Belgian
samples were obtained from individuals living in
Brussels (11/29 samples; 37.9%), followed by Wallonia
(18/62; 29.0%), and Flanders (6/98; 6.1%) (Fig. 2).
These numbers are representative for the current
structure of Belgian population, with important
migration waves in the past 50 years, mainly from
Southern Europe and Northern Africa, and with the
highest immigration numbers found in the Brussels
region [13].
The Belgian population is a typical European population
with genetic signals of recent migration from the African
continent
We first compared the genetic structure of the Belgian
population with other populations worldwide. To restrict
this analysis to the most informative and independent
SNPs, only SNPs located on autosomes with a minor allele
frequency of at least 5%, less than 2% missing values, and a
linkage disequilibrium lower than 0.2 were used for struc-
tural comparison. These filtering criteria resulted in a selec-
tion of 47,802 SNPs. These SNPs were used for a principal
component (PC) analysis using continental population data
(i.e., African, American, South Asian, East Asian, and
European populations) from the 1000 Genomes Project [1,
2, 14]. The main variance was captured by the first four
PCs (10.4%, Additional file 3: Figure S1a). Using the first
two PCs, which capture 5.2 and 3.2% of the total
variance respectively, an expected and clear separ-
ation was observed between the different continen-
tal populations, with the largest differences between
African, East Asian, and European populations
(Fig. 3). By applying this PC model on the Belgian
SNP genotype data, 184/189 samples were perfectly
mapped on the European population. The remaining
five samples were mapped towards or on the
African population, and for four of these samples,
an African origin was indeed confirmed in the NHIS
data (Fig. 3 and Additional file 3: Figure S1b). These
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Fig. 2 DNA sampling in the BelPHG-21 study, Belgium 2016. DNA was sampled and analyzed from 189 NHIS-2013 participants. The number of
collected samples is indicated for the three regions and 10 provinces. Numbers between brackets indicate the number of samples collected from
participants with a migration background. Main origins from migrants are indicated by the arrows. See Additional file 2: Table S2 for more details
and province abbreviations
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findings show that the genetic structure of the Belgian
population is a typical European population with signals
of recent migration from the African continent.
The genetic structure of the Belgian population mirrors
its geographical location in Europe
Our next goal was to examine how the Belgian population
differs from other European populations. After a similar
SNP filtering strategy as described above, the PC analysis
was repeated using the European populations from the
1000 Genomes Project. Only the first two PCs were
informative for a rather small variance of 0.76 and 0.35%
respectively (Additional file 4: Figure S2a). As expected, the
PC plot mimics European geography with a clear separ-
ation between Finnish, British, and South European popu-
lations. In agreement with this geographical orientation,
most of the Belgian population mapped between the British
and Southern European populations. Few samples mapped
closer or within the South European populations, and for
seven of these, a South European origin could indeed be
confirmed (Fig. 4 and Additional file 4: Figure S2b). These
data show the uniqueness of the Belgian genetic structure
in Europe with geographically related differences with the
other European populations.
Minor genetic differences between Flanders and Wallonia
To examine potential differences between the three main
geographic regions in Belgium, we excluded the 35 samples
with non-Belgian origins and indicated regional informa-
tion on the European PC model (Fig. 5). This PC analysis
demonstrates a minor but clear genetic substructure in the
Belgian population along a north-west to south-east geo-
graphic gradient, with Flemish inhabitants mapping in the
north-west, Walloon inhabitants mapping in the south-
east, and individuals from Brussels in between. A similar
analysis based on sample origin information from the 10
different provinces confirmed these geographic-related
genetic differences (Additional file 5: Figure S3).
To quantify the genetic differences between the three
Belgian regions and compare them with other European
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Fig. 3 Genetic variation of the Belgian population related to continental
populations. Plot of the first two principal components (PC) based on a
PC analysis using 47,802 SNPs from five continental populations as
indicated (AFR African, AMR American, EAS East Asian, EUR European,
SAS South Asian). Belgian data (BEL) were mapped independently. Total
variability captured by each PC is indicated by axis labels. For Belgian
samples with a migration background that map outside the European
population, the background is indicated. See main text for SNP
filtering criteria
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Fig. 4 Genetic variation of the Belgian population related to
other European populations. Plot of the first two principal
components (PC) based on a PC analysis using 41,083 SNPs from
five other European populations as indicated (GBR British, CEU
Utah Residents with Northern and Western European Ancestry,
FIN Finnish, IBS Iberian population in Spain, TSI Toscani in Italy).
Belgian data (BEL) were mapped independently. Total variability
captured by each PC is indicated by the axis labels. All Belgian
samples with a South European migration background are
indicated. See Additional file 4: Figure S2 for more details related
to migration backgrounds. See main text for SNP filtering criteria
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Fig. 5 Regional genetic variation within the Belgian population.
Belgian samples were mapped on the European PC model (41,083
SNPs) and colored based on the region of inhabitance as indicated
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populations, we calculated fixation indices (i.e., Fst values).
Fst is a metric with values between 0 and 1 that is used to
measure genetic distance between populations, in which
high pairwise values indicate large population differenti-
ation and vice versa. Fst values between the three Belgian
regions were very small (between 1.8 and 2.5e−04) and
smaller than with any other European population (Fst 3.2e
−04 or higher) (Table 2), confirming the results from the
PC analyses.
Finally, we correlated the variant allele frequencies of the
Belgian population with other European populations. This
analysis also allowed us to compare the Belgian population
to the geographically and linguistically related population
of the Netherlands, for which allele frequency data, but no
genotyping data, are publicly available (Genome of the
Netherlands project, GoNl [6]). As expected, and similar
to the PC and Fst analysis, extremely good correlations
were found with all European populations (Pearson correl-
ation coefficients of 0.972 and higher). The best correl-
ation was found with the GoNl data (Pearson correlation
coefficient of 0.992; Additional file 6: Figure S4).
In summary, these data show minor but clear genetic
differences between the different regions in Belgium with
a north-west to south-east geographical correlation. How-
ever, these differences were smaller than with any other
European population.
Discussion
The BelPHG-21 study aims at developing an approach
to estimate genetic variability at the level of the Belgian
population and exploring how this genetic information
can be associated with information collected via NHIS
questionnaires. Here, we reported on the genetic struc-
ture of the Belgian population using ± 300,000 genome-
wide SNPs, derived from saliva DNA sampled from 189
participants from the latest NHIS (2013). This is the first
study on the genetic structure of the Belgian population
and its regional differences. The Belgian population was
found to be a typical European population with signals
of recent migration from the African continent. Within
Europe, the Belgian population has its unique properties,
which clearly mirrors the geographic orientation and
again with signs of recent migration from Southern
Europe. While minor genetic differences were observed
between the different Belgian regions, these were smaller
than with any other population studied.
The linkage possibilities to health, demographic, and
related data from the NHIS provide a unique opportun-
ity to study the different factors that determine partici-
pation in a genetic study and to better understand
public willingness to participate in population genetic
research. Consent rates to participate in this study were
rather low (14%). Related studies that recruited people
with previous participation in health research reported
on variable consent rates between 21 and 85% [15–18].
The 3-year time gap between the NHIS and the second
contact, inviting participation in the BelPHG-21 study,
may be a reason for the relatively low participation rate.
Furthermore, subjects were contacted only by an invita-
tion letter (and reminder). We noted regional differences
in the consent rate, a higher consent for non-smokers
and a positive association with age and education level.
The higher likelihood of educated people to give consent
is in agreement with other studies [19–21]. The correl-
ation with age is more ambiguous, with reports of both
younger age as well as older age being associated with
lower consent [15, 20, 22]. The observation of smokers
to be less likely to provide consent is in contradiction to
other studies [23]. However, in our study, the difference
was attributed to a higher consent rate for former
smokers than for current smokers, while no significant
difference was observed between current smokers and
never smokers, indicating a more complex association
with smoking status.
The close mirroring of population genetic variation with
geography is a well-known phenomenon that has been de-
scribed at the European level previously [8, 9]. Novembre
et al. described a geographical map of Europe that arose
naturally as an efficient PCA-based two-dimensional sum-
mary of genetic variation in European individuals from
different countries (including 43 Belgians) [8]. This has
been shown not only on national, but also on regional levels,
Table 2 Fst pairwise genetic distances between Belgian regional and other European populations, BelPHG-21 study, Belgium 2016
GBR FIN IBS CEU TSI Flanders Wallonia Brussels
GBR 0
FIN 6.7e−03 0
IBS 2.4e−03 1.0e−02 0
CEU 3.2e−04 6.2e−03 2.2e−03 0
TSI 3.7e−03 1.1e−02 1.5e−03 3.3e−03 0
Flanders 6.5e−04 6.7e−03 1.9e−03 3.2e−04 2.7e−03 0
Wallonia 7.1e−04 7.1e−03 1.4e−03 4.1e−04 2.1e−03 2.5e−04 0
Brussels 6.5e−04 7.0e−03 1.8e−03 4.3e−04 2.5e−03 1.8e−04 1.8e−04 0
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as exemplified by genetic substructures that were observed
in Sweden [10, 24], Finland [7, 25], the Netherlands [6], and
several other European countries [9]. While this mirroring
of the Belgian genetic structure with its geographical orien-
tation in Europe was expected, it is quite remarkable to see
the same phenomenon at regional and to a lesser extent
even at provincial levels in a small country like Belgium.
Belgium is a country of immigration, with substan-
tial labor-related migration waves after the Second
World War [13]. This is reflected in this study, in
which 18.5% of the samples originated from individ-
uals with a migration background. Apart from the ex-
pected origin from neighboring countries, the most
frequent migration backgrounds were South European
and African, in agreement with migration data. This
non-Belgian origin was clearly reflected in the genetic
structure of the Belgian population. Information on
migration background was derived from NHIS data
and based on to the country of birth of the parents
of the study participant. While this study demon-
strated the usefulness of this type of NHIS-related in-
formation, there are some limitations. First, the
information is limited to the first generation only
(parents). This likely explains why one individual with
a clear non-European genetic background was not
found to have a migration background based on our
criteria, which is unlikely. Secondly, there is also a
risk of false positive migration findings as country of
birth does not necessarily imply the individual (or his
parents) originated in that country.
The NHIS contains information related to health, life-
style, environment, etc. [11]. Therefore, linking genetic
information to NHIS data has great potential for genome-
wide association studies. While the current sample size
(189) is rather limited, we will use the experience gathered
in this study to set up a larger genetic study linked to the
next NHIS (2018) where we aim to sequence the entire
genome from a representative sample of ± 1000 individ-
uals from the Belgian population using whole genome se-
quencing techniques. This genetic epidemiology study will
also give a concrete idea about the expected number of
harmful variants in the genome of a typical Belgian indi-
vidual, including the prevalence of several genetic disease
carriers. Results from these studies will be an invaluable
resource in the transition towards precision public health,
focusing on subsets of the population at increased risk,
rather than on the entire population.
Conclusions
This is the first study on the genetic structure of the Belgian
population and its regional variation. The Belgian popula-
tion is a typical European population with minor but clear
differences between the regions and clear signs of recent
migration.
Methods
BelPHG-21 study design
The BelPHG-21 study is a cross-sectional population-
based study, conducted in 2016. The study population
was selected from the participants of the most recent
(2013) NHIS. Persons from the German community
or with a missing national identification number were
excluded for logistic reasons. Only one member per
household was included, and the participants that did
not complete the auto-questionnaire part of the NHIS
in 2013 (which contains information on health, life-
style, and environment), that were deceased, deregis-
tered or with a discrepancy between self-reported and
calculated age were excluded. From the resulting 5768
eligible candidates, a random subsample of 1468 indi-
viduals was invited to participate in the BelPHG-21
study. Individuals were invited via postal mail. They
received an invitation letter with all the information
on the BelPHG-21 study as well as informed consent
forms to return in case of participation. Individuals
that consented to participate in the study were subse-
quently sent a saliva sample collection kit (Oragene®
saliva collection device (OG-500, DNA Genotek Inc.
Ottawa, Canada)) accompanied by an information let-
ter, a user manual for sample collection, a safety bag,
and a pre-paid and UN3373-labeled bubble. Each
package complied with the guidance on regulations
for the transport of infectious substances. All commu-
nication with study participants (consent, sampling
kits) was performed by a trusted third party (Belgian
Federal Service of Internal Affairs) that was not in-
volved in the downstream research in any way. They
submitted the received samples to the BelPHG-21 re-
search team and provided linking information to the
NHIS database.
Sample preparation and SNP array
Upon receipt of saliva samples by the BelPHG-21 re-
search team, DNA was manually extracted from the
total sample following the manufacturer’s instruc-
tions (DNA Genotek, PD-PR-015 Issue 10/2015-01).
DNA samples were quantified using UV absorbance,
and SNPs at ± 300,000 sites were determined using
the whole genome scanning 12-sample Illumina
HumanCytoSNP-12v2.1 BeadChip according to the
manufacturer’s instructions. Images were captured
on Cytoscan (Illumina), and data were primarily ana-
lyzed using Illumina’s GenomeStudio software.
NHIS data
Information related to the study participants’ resi-
dence (region and province), migration background,
and a set of variables that could influence the consent
rate was obtained from the NHIS-2013 database. A
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subject was considered to have a migration back-
ground when at least one of its parents was born out-
side of Belgium. The variables that were considered
to potentially influence consent rates were the back-
ground characteristics (demographic information, edu-
cation, employment, income), health behavior and
lifestyle characteristics (substance abuse, nutritional
status, physical activity), physical and social environ-
ment characteristics (housing, passive smoking), and
health and wellbeing characteristics (chronic diseases,
mental health, perceived health). Selection of the vari-
ables for the predictive model was conducted by
stepwise-weighted binomial regression analysis. Survey
weights were calculated based on age, gender, and re-
gion of residence.
Demographic and geographic data
Demographic data from the 2013 Belgian population
were downloaded from Eurostat (http://ec.europa.eu/
eurostat). Belgian geographic data were obtained using
the BelgiumMaps.Statbel R package (available at http://
www.datatailor.be/rcube/).
SNP data processing
Genotype calls were imported in R and converted in a sam-
ple x SNP matrix. Samples with genotyping call rates lower
than 0.6 were excluded from further analysis. All genotypes
were converted so that the reference allele always referred
to the positive strand of the human genome build hg19.
Genomic coordinates for all SNPs were retrieved from
dbSNP Build 144 [26]. SNPs not present in dbSNP were ex-
cluded from further analysis. The R SNPRelate package [27]
was used for downstream analysis (calculation of allele fre-
quencies, principal component analysis, …). Therefore,
genotyping data were first converted in genomic data struc-
ture (gds) format.
Principal component analysis
A principal component (PC) analysis was performed using
phase 3 data from 1000 genomes [2]. VCF and sample in-
formation data were downloaded from the 1000 genomes
ftp site (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/
20130502/), and genotype information from all SNPs over-
lapping with the BelPHG-21 study was extracted using the
R VariantAnnotation package [28]. Belgian data were
mapped independently on the PC model. The PC analysis
was performed using the most informative SNPs by apply-
ing the following filtering criteria: (1) SNPs measured in all
datasets, (2) lower than 2% missing values in both the 1000
genome dataset that was used to perform the PC analysis
and the Belgian data, (3) only autosomes, (4) minor allele
frequency higher than 5%, and (5) linkage disequilibrium
lower than 0.2.
Variant allele frequency correlations
Correlations between variant allele frequencies (VAF) were
determined using Pearson’s correlation. Correlations were
determined for SNPs after filtering using the higher men-
tioned criteria. Variant allele frequencies from the Genome
of the Netherlands (GoNl) project were derived from the
release 5 vcf files downloaded at https://molgenis26.targe-
t.rug.nl/downloads/gonl_public/variants/release5/.
Additional files
Additional file 1: Table S1. SNP variant allele frequencies of the
Belgian population, BelPHG-21 study, Belgium 2016. Variant allele frequencies
(VAF) for all SNPs were calculated with reference to the human genome
build hg19 on all samples or after exclusion of samples with a foreign origin
(indicated by tab names). Columns indicate SNP ids, chromosome, position,
reference allele, variant allele, VAF, and frequencies of homozygous reference
(AA), heterozygous (AB), and homozygous variant (BB) alleles respectively.
(XLSX 28534 kb)
Additional file 2: Table S2. Population details of the samples analyzed
in the BelPHG-21 study, Belgium 2016. Indication of the number of samples
taken from NHIS-2013 participants in each region and province, total number
of inhabitants in 2013, number of samples taken per million inhabitants,
number of invited participants, and sampling percentages. (XLSX 10 kb)
Additional file 3: Figure S1. Genetic variation of the Belgian
population related to continental populations. Principal component (PC)
analysis using 47,802 SNPs from five continental populations with
mapping of the Belgian population. (a) Screeplot showing the variability
captured by the first 10 PCs. (b) Pairwise plots of the first four PCs.
Populations are indicated below the plot (AFR: African; AMR: American;
EAS: East Asian; EUR: European; SAS: South Asian; BEL: Belgian). (PDF 7654 kb)
Additional file 4: Figure S2. Genetic variation of the Belgian
population related to other European populations. Principal component
(PC) analysis based on 41,083 SNPs from five different European
populations (see Fig. 4 for details). (a) Screeplot showing the variability
captured by the first 10 PCs. (b) PC plot of five European populations
with mapping of the Belgian population and indication of their migration
backgrounds. For visualization purposes, the other European populations
are shown in gray. (PDF 366 kb)
Additional file 5: Figure S3. Provincial genetic variation within the
Belgian population. Belgian data were mapped on the European PC
model (41,083 SNPs). Panels show plots of the first two PCs with
indication of the province of inhabitance as indicated. The central map of
Belgium shows the geographical location of each province. Panels with
Flemish provinces are shown on top while Walloon province panels are
shown on the bottom. (PDF 1806 kb)
Additional file 6: Figure S4. Variant allele frequency correlations
between Belgian and other populations. Variant allele frequencies (VAF)
for all SNPs were calculated with reference to the human genome build
hg19. Plots show the VAF of Belgian versus other continental (a) and
European (b) populations. Pearson correlation coefficients are shown on
top of each plot. For visualization purposes, only 1000 random points are
shown. (PDF 5259 kb)
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